ArticlePloS one2025
Derivation and validation of a model to predict treatment failure among under five children with severe community acquired pneumonia who are admitted at Debre Tabor specialized comprehensive hospital.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Community-Acquired Pneumonia in Young Children: Variables Associated With Emergency Department Attendance and Hospitalization.International journal of pediatrics · 2026Article
- Development and Validation of a Nomogram Model to Predict the Risk of Severe Pneumonia in Children with Pneumococcal Infection.Infection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSevere community-acquired pneumonia related treatment failure is persistence of features of severe pneumonia after initiation of antimicrobial therapy or a worsening clinical condition within 48-72 hours of the commencement of the antibiotics. Even though it is the most devastating public health problem in Ethiopia, there is no study to derivate and validate a model to predict treatment failure. To do this, nomogram was used to estimate the probability of treatment failure for each individual child and to classify their risk of treatment failure.
objectiveto develop and validate the model to predict treatment failure among under five children with severe community-acquired pneumonia in Debre Tabor comprehensive specialized hospital.
methodA secondary analysis of the previously collected prospective follow-up study was used for further analysis among 590 under-5 children hospitalized with severe community-acquired pneumonia. The STATA version 17 software was used for analysis. Descriptive analysis was summarized by frequency and percentage. A multivariable binary logistic regression was also conducted, and the model performance was evaluated using the receiver operating characteristics curve with its area under the curve and calibration curve. Internal validation of the model was assessed using the bootstrap technique. The decision curve analysis was also used to evaluate the usefulness of the nomogram.
resultsThe incidence of treatment failure among severe community-acquired pneumonia children was 28.1% (95% CI: 24.7%-30.8%). The previous history of severe community-acquired pneumonia, abnormal pulse rate, chest indrowing, anemia, HIV status, and plural effusion remained for the final model. The area under the curve for the original model and validated model was 0.7719 (95%CI: 0.729, 0.815) and 0.7714 (95% CI: 0.728-0.82), respectively. The decision curve analysis showed that the nomogram had a better net benefit across the threshold probability.
conclusionThe incidence of treatment failure among children with severe community-acquired pneumonia was high in Debre Tabor comprehensive hospital. The previous history of severe community-acquired pneumonia, abnormal pulse rate, chest indrowing, anemia, HIV status, and plural effusion were the significant factors to develop the predictive model. The model had good discriminatory performance and internally valid. Similarly, the model has a good calibration ability with an insignificant loss of accuracy from the original. The models can have the potential to improve treatment outcomes in the clinical settings. But needs external validation before use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.